Why the study?
Does morphometric analysis of endomyocardial biopsies improve diagnostic reliability in patients with suspected cardiomyopathy?
Does morphometric analysis of endomyocardial biopsies improve diagnostic reliability in patients with suspected cardiomyopathy?
Semiquantitative and morphometric methods on endomyocardial biopsies help define morphological changes in cardiomyopathy, though overlap limits individual diagnosis for some types like congestive cardiomyopathy.
No takes yet. Share an insight, caveat, or question.
Morphometric biopsy analysis supports group-level cardiomyopathy distinctions; leaves open reliable individual diagnosis due to overlap.
Baandrup et al. (1981) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: